CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Ty J. Gluckman, MD, FACC, FAHA | Charles Vega, MD, FAAFP
In the twenty-fifth episode of Pri-Med’s web series on COVID-19, faculty will approach the emerging and concerning concept of “long-haul” COVID-19. Additionally, this session will discuss postural orthostatic tachycardia syndrome (POTS) and the mechanisms connecting SARS-CoV-2 infection to POTS.
Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 02/09/2021 and they are subject to change as new information is published.
FACC, FAHA, Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA
Non-CME Unbranded Medical Education in collaboration with Amplifire digital Engineering learning tool
Axial spondyloarthritis (axSpA) is a chronic and debilitating inflammatory disease primarily affecting the spine and sacroiliac joints. In the United States alone, it is estimated to take 14 years to receive appropriate diagnosis as it's hallmark symptom, inflammatory back pain, can go unnoticed or be misdiagnosed. Due to the challenges in recognizing axSpA, patients are often referred to various healthcare providers in the journey to diagnosis. There is a significant need to increase the proper diagnosis of axSpA among healthcare professionals, especially those that are seeing patients experiencing back pain. Early identification and timely referral to rheumatologists can help mitigate the progressive structural damage and significant patient burden in axSpA patients.
This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.
Sponsored by Novartis Pharmaceutical Corporation